Positron Corp. (OTCMKTS:POSC) Short Interest Down 93.9% in June

Positron Corp. (OTCMKTS:POSC) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 44 shares, a decline of 93.9% from the May 31st total of 724 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 36,267 shares, the days-to-cover ratio is presently 0.0 days.

Positron Stock Performance

OTCMKTS:POSC traded up $0.03 during trading on Friday, reaching $1.88. The company’s stock had a trading volume of 5,900 shares, compared to its average volume of 60,764. The firm has a market cap of $61.59 million, a price-to-earnings ratio of -5.68 and a beta of 0.14. The firm has a 50 day moving average of $1.83 and a 200-day moving average of $1.84. Positron has a 12 month low of $1.27 and a 12 month high of $2.74.

Positron (OTCMKTS:POSC) last released its earnings results on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $0.11 million during the quarter. Positron had a negative net margin of 1,996.75% and a negative return on equity of 996.81%.

Positron Company Profile

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.